Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis

Antimicrobial Agents and Chemotherapy
Ariane de J Sousa-BatistaBartira Rossi-Bergmann

Abstract

The oral efficacy and safety of a leishmanicidal nitrochalcone (CH8) were studied in BALB/c mouse infections with Leishmania amazonensis and Leishmania infantum Although 10-fold-higher doses of CH8 were needed to produce the same antiparasitic effect as that seen with the reference drug miltefosine, the latter was nephrotoxic, whereas CH8 restored disease toxicity markers to normal. This study shows the therapeutic potential of an orally active and hepato-/nephroprotective chalcone against cutaneous and visceral leishmaniases.

References

May 1, 1999·Antimicrobial Agents and Chemotherapy·E C Torres-SantosB Rossi-Bergmann
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Cynthia DemicheliFrédéric Frézard
Feb 1, 1997·Parasitology Today·H C LimaR G Titus
Jan 3, 2006·Bioorganic & Medicinal Chemistry·Paula BoeckBartira Rossi-Bergmann
Apr 7, 2006·Expert Review of Anti-infective Therapy·Jaime Soto, Paula Soto
Feb 23, 2012·The Korean Journal of Parasitology·Solange dos Santos CostaSelma Giorgio
Jun 14, 2012·PloS One·Jorge AlvarUNKNOWN WHO Leishmaniasis Control Team
Jul 27, 2012·The Journal of Antimicrobial Chemotherapy·Thomas P C DorloPeter J de Vries
Jan 28, 2016·PLoS Neglected Tropical Diseases·Priscila L Dos SantosRoque P de Almeida
Oct 30, 2016·Drug Testing and Analysis·Swati JaiswalJawahar Lal
Jun 28, 2017·Parasitology·A J Sousa-BatistaB Rossi-Bergmann
Jul 3, 2017·International Journal of Antimicrobial Agents·Nasir TajuddeenMohammed Auwal Ibrahim
Dec 3, 2017·Journal of Global Antimicrobial Resistance·Ariane de J Sousa-BatistaRalph Santos-Oliveira
Dec 22, 2017·Antimicrobial Agents and Chemotherapy·Ariane de Jesus Sousa-BatistaBartira Rossi-Bergmann
Feb 8, 2018·Expert Review of Anti-infective Therapy·Fernanda VentinPaulo Roberto Lima Machado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Medical Journal, Armed Forces India
V K Agrawal, Zile Singh
Transactions of the Royal Society of Tropical Medicine and Hygiene
R Zeledón
Transactions of the Royal Society of Tropical Medicine and Hygiene
J A Rioux, G Lanotte
Santé : cahiers d'étude et de recherches francophones
J P Gangneux, P Marty
© 2022 Meta ULC. All rights reserved